Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-05-17 @ 2:08 PM
Study NCT ID:
NCT01261793
Status:
COMPLETED
Last Update Posted:
2020-12-04
First Post:
2010-12-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
Sponsor:
UCB Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SL0010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None